EEE CORP GROUP

Negin Bemanzadeh, an accomplished entrepreneur, investor, and visionary leader, is the founder and CEO of EEE Corp Group, a pioneering firm she established in 2012, leveraging her profound expertise and foresight in the financial, medical and life sciences sectors. With a dynamic start, Negin and her core team transitioned from a leading US investment bank. Under her leadership, EEE secured its first mandate from the Chairman of European Venture Capital Association. Demonstrating unparalleled leadership and strategic acumen, she expanded EEE into a globally recognized corporation within three years, establishing its presence in the UK & US. Under her stewardship, EEE became a crucible for innovation, attracting top-tier talent from renowned UK and US universities, fostering an environment of rigorous training and professional development in London as their pro-bono activities. Negin’s efforts were soon acknowledged as EEE attained accreditation by Foreign International Education, servicing prestigious institutions across the UK and the US.
Negin’s academic journey is as diverse as it is impressive, initially embarking on a path towards becoming a medical doctor and in parallel securing a degree in English Literature, and later on accounting, where she was trained by the UK’s Largest ACCA Practice, and later, by a leading US Investment bank in private equity, she continued to focus on the medical life sciences and specializing in life science projects. Her insatiable appetite for knowledge led her to pursue studies in Alternative Investments (Caia) and complete business studies at Harvard Business School 2021. As a leader one must display quality communication and technical skills, understand numbers and never seize to learn, this was the drive behind her diverse educational choices.
Negin’s influence and contributions have not gone unnoticed, earning her features in prestigious publications and interviews, including interviews at Spears Wealth Magazine in 2015, a notable interview with a BBC Correspondent in 2018 as a leading woman influencer to name a few. In 2019, Negin was honored with the British Community Honor’s Award at the House of Lords, recognizing her significant contributions and service to the British Community and financial services. She has also been an active participant at The World Economic Forum since 2020, further solidifying her role as a global thought leader. In 2021, she shared her insights with The American European Chamber of Commerce and continued to shape the discourse on healthcare innovation as a keynote speaker at various events, including the NHS Innovation Awards Ceremony 2022 and several elite private equity conferences in the United States in 2023. Negin led a pivotal role and engagement with NHS Innovation Hubs whereby she advanced the collaborative sharing process regarding scientific breakthroughs between the UK and the US. Further recognition came in 2023 by being an honored guest ‘at The Heroes of Military Medicine Awards Dinner in Washington D.C. and a few months later, Negin signed a significant MoU with The Henry M. Jackson Foundation, to jointly foster the ‘innovation ecosystem in life sciences for advancement of military medicine’, serving as HJF Partner at HJF Headquarters in Bethesda, MD.
In 2024, Negin was appointed to serve as a judge at ‘The NHS Innovation Awards Ceremony March 2024’ and interviewed as a ‘Happy CEO’ leading with purpose and passion in the same month. Negin ‘s leadership extends beyond the boardroom; she is a strategic partner to major institutions like the NHS (UK) and the Henry M. Jackson Foundation (US), spearheading initiatives that bridge the gap between life sciences and healthcare advancements across continents. Under her guidance, EEE stands as the sole private entity mandated to catalyze healthcare innovations, providing comprehensive support and expertise in scientific validation, IP analysis, design, manufacturing, labs and clinical sites facilitation, regulatory navigation, funding solutions, and accelerating their market integration within the two continents to ensure they are accessible to the populations of both jurisdictions thereby revolutionizing the healthcare landscapes of the UK and the US.
Residing between the UK and the US, Negin leads a team of distinguished experts delivering exceptional outcomes across multiple time zones. Her commitment to excellence, strategic partnerships, and a carefully curated portfolio of mandates underscores her and EEE’s pivotal role in enhancing global health care and medical innovation. Through her leadership, EEE embodies the vision of a healthier future, driven by cross-continental collaboration, and cutting-edge solutions in life sciences and healthcare technology.
EEE acts as a bridge between the UK and the US in enhancing Life Sciences, Healthcare, Medical Devices, and Health Tech projects.
Negin’s visionary leadership and unwavering commitment to fostering international cooperation in the health and life sciences sectors have positioned EEE as a beacon of innovation and excellence, making significant contributions to global health care advancements. A mission that led to her being approved for her self-petitioned Green Card in the US under EB1-A (People with extra-ordinary ability), in just 8 days.
She believes strongly in recognizing the significance of cross-collaboration, diversity and outside the box thinking while nurturing every relationship irrespective of the differences.

Negin Bemanzadeh

The Founding CEO

John has served as an executive and investor for 20 years in life sciences and health technology. As an investor, he was a Managing Director at Miraki Innovation, an early-stage MedTech VC fund which founded Auris Health, acquired by Johnson & Johnson for $5.75B. He was co-founder of Tufts Health Ventures, the VC, PE and LP investment division of Tufts Health Plan, a $5B revenue payer, investing $250M in digital health technologies such as Iora Health, acquired by Amazon. As an operator, he was previously Head of Corporate Development for 3BL Media, a media company which provides digital ESG solutions for 500 employers. He held executive roles at iRobot, ReMed Life Sciences and miR Scientific executing investments, partnerships and M&A deals. Mr. Dvor earned his Bachelor’s Degree from Harvard University. His career started in the US Marine Corps at The White House 1998-2003 as US Secret Service Attaché, serving during the Clinton and Bush Administrations, traveling on 30+ Advance Travel Missions, and was awarded Presidential Service Badge #17996. John shall lead business operations Boston and is and has been an immense valuable asset to EEE since start unofficially and now officially.

Mr. John Dvor,

Partner, Cambridge Massachusetts

Anthony is a seasoned healthcare executive with over two decades of experience, including leadership roles as the Chief Administrative Officer for 20 Community Hospital Outpatient Clinics in Southern California. His expertise spans strategic growth initiatives, acquisition integrations, patient-centered care enhancements, and turnaround projects. Dr. Russell holds double board certifications in pediatrics and clinical informatics and has held senior and executive positions at esteemed healthcare systems in California. He received his education and training at Medical University of South Carolina, Johns Hopkins University, University of Massachusetts (Amherst), and UCSF. Currently, Dr Russell serves as Chairman on two private healthcare boards, participates on the two medical advisory boards, and invests in multiple private equity holdings. Anthony shall be heading our EEE Corporate Group Delaware branch in the West Coast from our offices in Los Angeles, while Charles continues to head our UK operations.

Dr. Anthony Russell,

Partner, West Coast

Charles serves as Head of UK Operations and deploys his many years’ experience to ensure appropriate strategies and business model. Charles is a business valuation specialist and ensures best practice with IP and market opportunity taken into account. Charles has an MBA (with award) from Henley Business Management School and 20 years’ experience in valuing and turning around promising entities. Additionally, he has the experience of operational control of organizations of £100m on the one hand to bringing about significant growth of small fledgling groups on the other.

Charles Brooks

Global Head Of Operations

Is an IP Lawyer with especial focus on licensing and monetisation strategy and has worked in the sector for over 30 years, largely in private practise here in the UK as principal of his business ISS and as Counsel for EEE Group.He holds an LLB (Hons) in law, an M.Phil (summa cum lauda) in international licensing and is Chair and Fellow of the Institute of Intellectual Property Licensing; F.I.I.L.P.He is currently Vice-Chair of IPAN the all sector Intellectual Property Awareness Network which is representative of respectively: academia; commerce; industry and; many related professions, whose mission is the better promotion and understanding of IP.He has been Sometime Lecturer in IP Licensing at Brunel University of London and published widely on all matters related to the exploitation of IP assets.

Nigel Worth

IP Counsel

Caroline is an accomplished Ex-Medical Paracticioner who has developed growth and innovation strategies for private and public companies in North America, Europe and Asia. During a 10-year career at Becton Dickinson (NYSE: BDX), Dr. Popper’s global responsibilities included clinical affairs, marketing, strategy, and business development. She was the founding General Manager of BDGene, an internal start-up focused, with its partner Millennium Pharmaceuticals, on development of novel molecular diagnostics. She was subsequently responsible for Diagnostic Strategy at bioMerieux and thereafter was the Chief Business Officer for MDS Proteomics, a drug discovery company with operations in the U.S., Canada and Europe. She has founded several companies in diagnostics and pharma services and participates as an independent director on several company boards. She received her medical degree from the University of the Witwatersrand (South Africa) and her M.P.H. from Johns Hopkins University (Baltimore). Caroline shall be heading our DC office while Charles continues to head our UK operations.

Dr Caroline Popper

Senior Pharma Innovations Advisor East Coast Operations

Chi has been serving as Negin’s Executive Assistant for years, providing her with all her Executive briefings before every meeting. Chi obtained her Master’s Degree with Distinction in Banking and Finance from the University of Nottingham. Chi is continuously engaged in Banking Risk Management and prior to serving as Negin’s EA, she had worked in Banking Supervision and Sales Management. She has an eye for details and is extremely up to date with IMF and the regulatory framework applying to our sectors of investments.

Chi Nguyen

Executive Assistant To Negin

Kia serves as EEE’s Investor Relations Associate US.Prior to graduating in business and finance with distinction from the university of Essex, he finished International Baccalaureate in the City of London and majored in Life Sciences while being awarded Duke of Edinburgh Gold accolade. Kia has many talents and not only he is excellent at building excellent worldwide relationships but also, he managed to build a successful online store in parallel to all his other internships, part time careers and his full-time education financing his own life and ventures from an early age. He is now serving the team as Investor Relations Associate and works closely with the team on information flow, executive summaries, and market trends. He has successfully completed computer coding and business analytics at HBS Online and has been awarded scholarship to continue with his master’s degree in Applied Mathematics.

Kia Reza

EEE’s Investor Relations Associate

Minh serves as Charles’ Personal Assistant at EEE and is instrumental in conducting research on a short timescale. Minh achieved her Master's Degree with Distinction in Banking and Finance from the University of Nottingham. Before joining EEE, Minh had been a Credit Analyst with experience working alongside the Executive team of one of the largest banks in the world. She has obtained a MCBI/Chartered Banker's certificate which are truly complemented by her skills and experiences in Retail/Wholesales Banking. She has also completed thorough training on IP Diligence under EEE's Head of IP.

Minh Nguyen

Personal Assistant To Charles

Dr. Carrie Kuehn is a talented medical device regulatory and clinical affairs professional with a diverse background and over 25 years of experience in research epidemiology, medical devices, regulatory and clinical affairs, and patient-focused policy. In practice, Dr. Kuehn applies her expertise, leadership, strategic remediation skills, and broad medical device clinical-regulatory knowledge to address the needs of medical products companies and stakeholders across therapeutic areas. Dr. Kuehn excels at taking complex, multidisciplinary problems and synthesizing them into a cohesive strategy. She is particularly skilled at stepping into crises, supporting remediation efforts, conducting gap analyses, reorienting strategic plans, and bringing positive results out of fire-drill situations. Dr. Kuehn applies her adaptable skill set to address complex issues in the pre-market and post-market space to enhance compliance, fine tune business practice, and improve patient lives around the world. With the increase in clinical requirements being imposed on medical device companies globally, Carrie can provide critical expertise in real-world evidence generation, regulatory affairs, and observational and clinical research methods, execution, and publication of clinical results to achieve and maintain market authorization. An accomplished researcher, Dr. Kuehn has published in the areas of epidemiology, regulatory affairs, and patient engagement policy. She also maintains a blog covering topics relevant to medical regulatory affairs practice and patient-focused policy. As faculty in the RAQA Graduate Program at Temple University and in the Regulatory Affairs Graduate Program at the Hong Kong University of Science and Technology, Dr. Kuehn helps to prepare the next generation of patient-focused, medical device regulatory professionals

Carrie M. Kuehn

MA, MPH, DLP, RAC-US Regulatory Counsel